Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-2,page-paged-2,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Rentschler Biopharma SE: Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
    www.rentschler-biopharma.com
  • Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
    www.relieftherapeutics.com
  • RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
    www.redhillbio.com
  • Lindis Blood Care Initiates Multicenter Clinical EU Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood
    www.lindis-bloodcare.com
  • VAXIMM to Participate at Upcoming Scientific and Industry Events
    www.vaximm.com
  • XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
    www.xphyto.com
  • ADOCIA Announces its Full Year Financial Results 2020 And Provides Corporate Update
    www.adocia.com
  • Newron announces 2020 financial results and provides outlook for 2021
    www.newron.com
  • Relief Reports that NeuroRx has Announced Feasibility Collaboration with TFF Pharmaceuticals
    www.relieftherapeutics.com
  • Marinomed Biotech AG Enrolls First Patients in Phase II Clinical Trial of Tacrosolv to Treat Allergic Rhinoconjunctivitis (Hay Fever)
    www.marinomed.com